Rockwell Medical Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 87.7% | 85.2% | 83.8% | 88.7% | 92.7% | 108.3% | 99.8% | 126.9% | 88.2% | 93.0% | 93.5% | 95.1% | 100.1% | 92.8% | 93.0% | 94.5% | 97.7% | 97.5% | 97.4% | 101.7% | 102.1% | 114.6% | 104.9% | 90.7% | 95.8% | 87.9% | 86.8% | 94.3% | 90.7% | 87.0% | 86.5% | 82.4% | 78.0% | 85.3% | 83.9% | 84.4% | 85.7% | 78.9% | 83.3% | 81.8% | 82.3% | |
| 12.3% | 14.8% | 16.2% | 11.3% | 7.3% | -8.3% | 0.2% | -26.9% | 11.8% | 7.0% | 6.5% | 4.9% | -0.1% | 7.2% | 7.0% | 5.5% | 2.3% | 2.5% | 2.6% | -1.7% | -2.1% | -14.6% | -4.9% | 9.3% | 4.2% | 12.1% | 13.2% | 5.7% | 9.3% | 13.0% | 13.5% | 17.6% | 22.0% | 14.7% | 16.1% | 15.6% | 14.3% | 21.1% | 16.7% | 18.2% | 17.7% | |
| 9.8% | 9.0% | 8.3% | 12.7% | 8.9% | 14.3% | 11.1% | 10.5% | 4.8% | 16.1% | 3.2% | 19.9% | 9.6% | 12.6% | 11.5% | 10.2% | 11.4% | 12.6% | 11.7% | 16.0% | 7.6% | 9.1% | 9.7% | 5.0% | 2.5% | 0.8% | 1.4% | 0.9% | 2.1% | 0.8% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.2% | – | |
| 39.6% | 45.2% | 41.8% | 49.4% | 32.8% | 39.6% | 20.9% | 37.1% | 36.2% | 45.2% | 40.0% | 37.0% | 30.0% | 30.1% | 33.3% | 18.1% | 23.7% | 29.1% | 25.4% | 24.3% | 24.3% | 30.9% | 23.7% | 25.6% | 17.4% | 19.7% | 16.5% | 18.2% | 12.2% | 12.3% | 16.7% | 13.4% | 12.6% | 13.4% | 19.5% | 20.4% | 20.9% | 20.4% | 22.0% | 20.7% | 21.0% | |
| 49.4% | 54.1% | 50.1% | 62.0% | 41.7% | 53.9% | 45.0% | 48.6% | 41.8% | 62.9% | 63.1% | 71.9% | 51.4% | 55.0% | 57.8% | 40.8% | 46.0% | 55.8% | 49.0% | 50.0% | 41.5% | 154.5% | 36.2% | 33.3% | 24.0% | 22.3% | 20.5% | 22.1% | 16.6% | 15.5% | 19.4% | 15.6% | 15.2% | 16.8% | 23.3% | 24.0% | 24.2% | 23.3% | 25.2% | 24.2% | 24.2% | |
| -37.1% | -39.3% | -34.0% | -50.7% | -34.4% | -62.1% | -44.8% | -82.5% | -30.0% | -55.9% | -56.6% | -69.9% | -51.5% | -47.8% | -50.8% | -35.2% | -43.8% | -53.2% | -46.4% | -51.7% | -43.6% | -54.5% | -41.1% | -24.0% | -19.8% | -10.2% | -7.3% | -16.4% | -7.3% | -2.5% | -5.8% | 2.0% | 6.8% | -2.1% | -7.2% | -8.4% | -9.9% | -2.2% | -8.5% | -6.0% | -6.5% | |
| 0.0% | 150,926.5% | 0.0% | 2.8% | 0.2% | 1.2% | 1.2% | 0.0% | 0.0% | 0.0% | – | – | – | – | 0.6% | 3.3% | 4.4% | 3.9% | 3.8% | 3.9% | 3.8% | 3.8% | 3.3% | 2.6% | 2.5% | 2.3% | 2.0% | 2.2% | 1.7% | 5.0% | 1.9% | 0.9% | 1.1% | 1.2% | 1.5% | 1.7% | 1.8% | 1.6% | 1.6% | 1.6% | 1.6% | |
| -35.6% | -37.7% | -32.5% | -53.5% | -34.6% | -60.9% | -43.7% | -82.0% | -29.8% | -55.6% | -55.8% | -69.3% | -51.0% | -47.1% | -50.4% | -43.4% | -48.1% | -57.1% | -50.1% | -55.5% | -47.4% | -58.3% | -44.4% | -26.6% | -22.4% | -12.2% | -8.9% | -18.3% | -7.9% | -6.8% | -7.6% | 1.3% | 5.9% | -3.1% | -8.0% | -9.3% | -11.0% | -3.0% | -9.3% | -6.6% | -7.3% | |
| 0.0% | 3,018.1% | 0.0% | -2.8% | 0.0% | -2.1% | 0.0% | -0.4% | -1.1% | -1.4% | -0.8% | -5.2% | -0.6% | -4.8% | 0.6% | -2.0% | 4.4% | 57.1% | 0.1% | 3.9% | – | – | 3.3% | 2.6% | 2.6% | 2.0% | 3.6% | 0.3% | -2.4% | -0.9% | -2.4% | 0.2% | – | – | – | – | – | – | – | – | – | |
| -35.6% | -37.7% | -32.5% | -53.5% | -34.6% | -60.9% | -43.7% | -82.0% | -29.8% | -55.6% | -55.8% | -69.3% | -51.0% | -47.1% | -50.3% | -43.4% | -48.1% | -57.1% | -50.1% | -55.5% | -47.4% | -58.3% | -44.4% | -26.6% | -22.4% | -12.2% | -8.9% | -18.3% | -7.9% | -6.8% | -7.6% | 1.3% | 5.9% | -3.1% | -8.0% | -9.3% | -11.0% | -3.0% | -9.3% | -6.6% | -7.3% | |
| -35.6% | -38.0% | -33.1% | -49.8% | -33.5% | -61.3% | -37.4% | -74.5% | -28.9% | -54.5% | -51.5% | -64.7% | -46.7% | -43.7% | -45.9% | -36.6% | -40.2% | -49.4% | -42.4% | -47.5% | -39.8% | -50.1% | -40.2% | -23.2% | -19.1% | -6.6% | -6.1% | -15.2% | -3.8% | 0.7% | -3.3% | 4.4% | 8.9% | 0.3% | -3.7% | -4.1% | -5.8% | 1.5% | -4.7% | -2.2% | -2.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.